771 related articles for article (PubMed ID: 31438973)
1. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
2. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
[TBL] [Abstract][Full Text] [Related]
3. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
[TBL] [Abstract][Full Text] [Related]
4. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
[TBL] [Abstract][Full Text] [Related]
5. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
[TBL] [Abstract][Full Text] [Related]
6. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
Ishizawa M; Ganbaatar U; Hasegawa A; Takatsuka N; Kondo N; Yoneda T; Katagiri K; Masuda T; Utsunomiya A; Kannagi M
Cancer Sci; 2021 Mar; 112(3):1161-1172. PubMed ID: 33410215
[TBL] [Abstract][Full Text] [Related]
7. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
Furukawa Y; Kubota R; Tara M; Izumo S; Osame M
Blood; 2001 Feb; 97(4):987-93. PubMed ID: 11159527
[TBL] [Abstract][Full Text] [Related]
8. Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.
Manuel SL; Sehgal M; Connolly J; Makedonas G; Khan ZK; Gardner J; Betts MR; Jain P
J Clin Immunol; 2013 Oct; 33(7):1223-39. PubMed ID: 23888327
[TBL] [Abstract][Full Text] [Related]
9. Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis.
Mozhgani SH; Jahantigh HR; Rafatpanah H; Valizadeh N; Mohammadi A; Basharkhah S; Rezaee SA
Neurodegener Dis; 2018; 18(2-3):150-155. PubMed ID: 29990995
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
Araya N; Sato T; Yagishita N; Ando H; Utsunomiya A; Jacobson S; Yamano Y
Viruses; 2011 Sep; 3(9):1532-48. PubMed ID: 21994794
[TBL] [Abstract][Full Text] [Related]
11. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL].
Tanaka Y; Kanda Y
Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
[TBL] [Abstract][Full Text] [Related]
13. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
15. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
16. IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.
Sawada L; Nagano Y; Hasegawa A; Kanai H; Nogami K; Ito S; Sato T; Yamano Y; Tanaka Y; Masuda T; Kannagi M
PLoS Pathog; 2017 Sep; 13(9):e1006597. PubMed ID: 28910419
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.
Kannagi M; Hasegawa A; Nagano Y; Iino T; Okamura J; Suehiro Y
Cancer Sci; 2019 Mar; 110(3):849-857. PubMed ID: 30666755
[TBL] [Abstract][Full Text] [Related]
18. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
19. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
20. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
